Adaptive Biotechnologies Corporation reiterated revenue guidance for the full year 2023. The company reiterates full year 2023 revenue to be in the range of $205 million to $215 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | -0.38% | +8.33% | -46.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.94% | 383M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
+13.32% | 332M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Reiterates Revenue Guidance for the Full Year 2023